D. M. Aronoff, C. Canetti, and M. Peters-golden, Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP, J Immunol, vol.173, pp.559-565, 2004.

M. Berguerand, E. Klapisz, G. Thomas, L. Humbert, A. M. Jouniaux et al., Differential stimulation of cytosolic phospholipase A2 by bradykinin in human cystic fibrosis cell lines, Am J Respir Cell Mol Biol, vol.17, pp.481-490, 1997.

P. Braquet, L. Touqui, T. Y. Shen, and B. B. Vargaftig, Perspectives in platelet-activating factor research, Pharmacol Rev, vol.39, pp.97-145, 1987.

S. Caristi, G. Piraino, M. Cucinotta, A. Valenti, S. Loddo et al., , pp.2-8

, gene transcription by activating C/EBP homologous protein in human T lymphocytes, J Biol Chem, 2005.

P. B. Davis, D. M. Konstan, and M. W. Cystic, Am J Respir Crit Care Med, vol.154, pp.1229-1256, 1996.

G. M. Denning, M. P. Anderson, J. F. Amara, J. Marshall, A. E. Smith et al.,

, Processing of mutant cystic fibrosis transmembrane conductance regulator is temperaturesensitive, Nature, vol.358, pp.761-764, 1992.

E. A. Dennis, Phospholipase A2 in eicosanoid generation, Am J Respir Crit Care Med, vol.161, pp.32-35, 2000.

M. E. Egan, J. Glockner-pagel, C. Ambrose, P. A. Cahill, L. Pappoe et al., Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells, Nat Med, vol.8, pp.485-492, 2002.

M. A. Fiedler, K. Wernke-dollries, and J. M. Stark, Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132, Am J Respir Cell Mol Biol, vol.19, pp.259-268, 1998.

J. Fink, J. H. Steer, D. A. Joyce, A. S. Mcwilliam, and G. A. Stewart, Pro-inflammatory effects of Burkholderia cepacia on cystic fibrosis respiratory epithelium, FEMS Immunol Med Microbiol, vol.38, pp.273-282, 2003.

R. Franson, P. Patriarca, and P. Elsbach, Phospholipid metabolism by phagocytic cells

, Phospholipases A2 associated with rabbit polymorphonuclear leukocyte granules, J Lipid Res, vol.15, pp.380-388, 1974.

R. L. Gibson, J. L. Burns, and R. Bw, Pathophysiology and management of pulmonary infections in cystic fibrosis, Am J Respir Crit Care Med, vol.168, pp.918-951, 2003.

B. Goudeau, F. Huetz, S. Samson, D. Santo, J. P. Cumano et al., IkappaBalpha/IkappaBepsilon deficiency reveals that a critical NF-kappaB dosage is required for lymphocyte survival, Proc Natl Acad Sci U S A, vol.100, pp.15800-15805, 2003.

L. Guillot, S. Medjane, K. Le-barillec, V. Balloy, C. Danel et al.,

M. , Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4, J Biol Chem, vol.279, pp.2712-2718, 2004.

S. C. Hyde, P. Emsley, M. J. Hartshorn, M. M. Mimmack, U. Gileadi et al., Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport, Nature, vol.346, pp.362-365, 1990.

J. P. Kemp, Recent advances in the management of asthma using leukotriene modifiers, Am J Respir Med, vol.2, pp.139-156, 2003.

T. Z. Khan, J. S. Wagener, T. Bost, J. Martinez, A. Fj et al., Early pulmonary inflammation in infants with cystic fibrosis, Am J Respir Crit Care Med, vol.151, pp.1075-1082, 1995.

M. W. Konstan, R. W. Walenga, K. A. Hilliard, and J. B. Hilliard, Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis, Am Rev Respir Dis, vol.148, pp.896-901, 1993.

H. Kuwata, S. Yamamoto, Y. Miyazaki, S. Shimbara, Y. Nakatani et al., Studies on a mechanism by which cytosolic phospholipase A2 regulates the expression and function of type IIA secretory phospholipase A2, J Immunol, vol.165, pp.4024-4031, 2000.

M. Lemnaouar, E. Chastre, A. Paul, M. Mergey, D. Veissiere et al., Oncogene-mediated propagation of tracheal epithelial cells from two cystic fibrosis fetuses with different mutations. Characterization of CFT-1 and CFT-2 cells in culture, Eur J Clin Invest, vol.23, pp.151-160, 1993.

Y. C. Lio, L. J. Reynolds, J. Balsinde, and E. A. Dennis, Irreversible inhibition of Ca(2+)-independent phospholipase A2 by methyl arachidonyl fluorophosphonate, Biochim Biophys Acta, vol.1302, pp.55-60, 1996.

L. Miele, E. Cordella-miele, M. Xing, R. Frizzell, and A. B. Mukherjee, Cystic fibrosis gene mutation (deltaF508) is associated with an intrinsic abnormality in Ca2+-induced arachidonic acid release by epithelial cells, DNA Cell Biol, vol.16, pp.749-759, 1997.

M. S. Muhlebach, P. W. Stewart, L. Mw, and T. L. Noah, Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients, Am J Respir Crit Care Med, vol.160, pp.186-191, 1999.

F. Ratjen and G. Doring, Cystic fibrosis, Lancet, vol.361, pp.681-689, 2003.
URL : https://hal.archives-ouvertes.fr/hal-01361411

J. R. Riordan, J. M. Rommens, B. Kerem, N. Alon, R. Rozmahel et al., Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, Science, vol.245, pp.1066-1073, 1989.

H. C. Rodgers, L. Pang, E. Holland, L. Corbett, S. Range et al., Bradykinin increases IL-8 generation in airway epithelial cells via COX-2-derived prostanoids, Am J Physiol Lung Cell Mol Physiol, vol.283, pp.612-618, 2002.

R. W. Schevitz, N. J. Bach, D. G. Carlson, N. Y. Chirgadze, D. K. Clawson et al., Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2, Nat Struct Biol, vol.2, pp.458-465, 1995.

S. Tavakoli, M. J. Cowan, T. Benfield, C. Logun, and J. H. Shelhamer, Prostaglandin E(2)-induced interleukin-6 release by a human airway epithelial cell line, Am J Physiol Lung Cell Mol Physiol, vol.280, pp.127-133, 2001.

L. Touqui, A. , and M. , Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases, Curr Mol Med, vol.1, pp.739-754, 2001.

A. Venkatakrishnan, A. A. Stecenko, G. King, T. R. Blackwell, K. L. Brigham et al., Exaggerated activation of nuclear factor-kappaB and altered

, IkappaB-beta processing in cystic fibrosis bronchial epithelial cells, Am J Respir Cell Mol Biol, vol.23, pp.396-403, 2000.

C. L. Ward and R. R. Kopito, Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins, J Biol Chem, vol.269, pp.25710-25718, 1994.

Y. Xu, J. C. Clark, B. J. Aronow, C. R. Dey, C. Liu et al.,

, Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency

, J Biol Chem, vol.278, pp.7674-7682, 2003.

P. L. Zeitlin, L. Lu, J. Rhim, G. Cutting, G. Stetten et al., A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection, Am J Respir Cell Mol Biol, vol.4, pp.313-319, 1991.